表 1. Comparison of the general data and anesthesia and operation data of patients in the three groups.
三组患者一般情况和麻醉手术资料比较
| Indicator | Control group (n=43) | R group (n=43) | RD group (n=43) |
| BMI: body mass index; ASA: American Society of Anesthesiologists; FEV1: forced expiratory volume in one second; FVC: forced vital capacity. | |||
Age/yr., 
|
61.5±7.5 | 60.5±8.3 | 62±9.1 |
| (Male/female)/case | 23/20 | 25/18 | 26/17 |
BMI/(kg/m2), 
|
22.3±2.1 | 22.1±2.2 | 21.5±1.8 |
|
ASA classification ratio (Ⅰ/Ⅱ/Ⅲ)/case |
4/25/14 | 3/23/17 | 5/22/16 |
(FEV1/FVC)/%, 
|
75.8±6.2 | 79.5±6.8 | 77.6±6.5 |
| Complications/case (%) | |||
| Hypertension | 20 (46.5) | 22 (51.2) | 24 (55.8) |
| Diabetes | 6 (14.0) | 8 (18.6) | 7 (16.3) |
| Coronary heart disease | 4 (9.3) | 4 (9.3) | 5 (11.3) |
Anesthesia time/min, 
|
109.2±15.7 | 112.5±17.2 | 105.8±15.6 |
| The operation type/case (%) | |||
| Lobectomy of lung | 17 (40.0) | 20 (46.5) | 19 (44.2) |
| Segmental resection of lung | 14 (32.6) | 13 (30.2) | 15 (34.9) |
| Wedge resection of lung | 12 (27.9) | 10 (23.3) | 9 (20.9) |
|
Intraoperative opioid dose/(µg/kg), | |||
| Sufentanil | 0.63±0.05 | 0.66±0.05 | 0.68±0.05 |
| Remifentanil | 16.8±2.6 | 16.3±2.8 | 17.5±2.5 |
